INHIBITOR FOR THE ONSET AND PROGRESS OF LIVER CANCER TO BE USED IN HEPATITIS C VIRUS-POSITIVE HUMAN LIVER CIRRHOSIS PATIENTS
Application 648/CHENP/2007 published 2007-08-24, filed 2007-02-14
The present invention provides, as a pharmaceutical agent having an effect to inhibit the development and/or progression of liver cancer in hepatitis C virus-positive human cirrhosis patients, an agent for inhibiting the development and/or progression of liver cancer in hepatitis C virus-positive human cirrhosis patients, which contains three kinds of amino acids of isoleucine, leucine and valine.
Applicant
1)AJINOMOTO CO, INC
:15-1, KYOBASHI 1-CHOME, CHUO-KU, TOKYO 104-8315, Japan
Inventor
1)KUMADA, HIROMITSU 2)MUTO, YASUTOSHI 3)SATO, SHUNICHI 4)WATANABE, AKIHARU
International Info
Classification: A61P 35/00
Publication Number: WO 2006/006729 A1
Application Date: 2005-07-13
Priority Information
2004-207693 Japan 2004-07-14